[Federal Register: June 9, 2009 (Volume 74, Number 109)]
[Notices]
[Page 27350]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr09jn09-103]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on March 18, 2009, Norac Inc.,
405 S. Motor Avenue, P.O. Box 577, Azusa, California 91702-3232, made
application by letter to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of Nabilone (7379), a basic class
of controlled substance listed in schedule II.
    The company plans to manufacture bulk controlled substances for use
in product development and for distribution to its customers.
    Any other such applicant, and any person who is presently
registered with DEA to manufacture such a substance, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than August 10, 2009.

    Dated: June 3, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-13351 Filed 6-8-09; 8:45 am]

BILLING CODE 4410-09-P